Study guide

DKA, HHS and complication monitoring

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

DKA, HHS and complication monitoring

Key Takeaways Explain This Topic AI

In adult DKA, potassium below 3.5 mmol/L requires replacement before insulin.

Continue insulin with added glucose when needed until ketoacidosis resolves.

Avoid overly rapid osmotic changes when treating HHS.

Last updated: October 2026

Diabetic ketoacidosis

Insulin deficiency permits lipolysis and ketogenesis; acidosis, osmotic diuresis and vomiting cause major fluid and electrolyte losses. The 2024 adult consensus requires diabetes/hyperglycaemia (glucose at least 11.1 mmol/L or known diabetes), ketosis (blood beta-hydroxybutyrate at least 3 mmol/L or significant urine ketones), and acidosis (pH below 7.3 or bicarbonate below 18 mmol/L). SGLT2-associated DKA may have little glucose elevation. Check ketones when an unwell patient taking an SGLT2 inhibitor has nausea, abdominal pain or tachypnoea.

Seek the precipitant: infection, insulin interruption, infarction, pregnancy, pancreatitis or medicines. Assess airway, perfusion, mental state, fluid deficit and ECG, with glucose, ketones, electrolytes, kidney function and venous blood gas. Potassium can be normal or high despite a substantial total-body deficit.

Treatment combines isotonic fluid, insulin and potassium monitoring under a validated hospital protocol. Rates must reflect age, cardiac and renal function. If potassium is below 3.5 mmol/L, replace it and defer insulin until it is above that level; insulin shifts potassium intracellularly and can provoke arrhythmia. Replacement rates require appropriate venous access, monitoring and local limits, not an unmonitored 20–40 mmol/h prescription.

For significant adult DKA, an insulin infusion is commonly started at 0.1 units/kg/h after potassium safety is established. Once glucose falls below 13.9 mmol/L, the consensus recommends adding dextrose and reducing insulin to about 0.05 units/kg/h. Continue insulin to suppress ketogenesis; do not stop simply because glucose normalises. Reassess glucose frequently and ketones, pH, potassium and fluid balance serially. Bicarbonate is not routine.

Resolution uses ketone clearance with correction of acidosis, not glucose alone. Hyperchloraemic acidosis during recovery can confuse anion-gap interpretation. Give subcutaneous basal insulin with the appropriate overlap before stopping an infusion, restore nutrition safely, and address education, sick-day rules and access to insulin.

Hyperglycaemic hyperosmolar state

HHS features severe hyperglycaemia, hyperosmolality and dehydration without the degree of ketosis/acidosis characteristic of DKA. The adult consensus includes glucose at least 33.3 mmol/L, effective osmolality above 300 mOsm/kg or total osmolality above 320, beta-hydroxybutyrate below 3 and no substantial acidosis (pH at least 7.3 and bicarbonate at least 15). Mixed DKA/HHS exists and needs a pathway addressing both.

Effective calculated osmolality in SI units is 2 × sodium + glucose; total calculated osmolality additionally includes urea. For sodium 152 and glucose 48.2, effective osmolality is 304 + 48.2 = 352.2 mOsm/kg. State which equation is being used rather than switching thresholds silently.

Restore circulation carefully, monitor glucose, sodium, potassium, urine output and osmolality, and identify the trigger. Older patients often have cardiac or renal disease, so a universal fluid timetable is unsafe. An osmolality decline of about 3–8 mOsm/kg/h is a consensus safety goal; avoid rapid shifts. Initial fluid itself lowers glucose. Insulin timing and dose differ from DKA when ketosis is absent; use the local protocol and obtain senior input. Assess thrombosis risk and give appropriate prophylaxis unless contraindicated.

DKA/HHS response example

In a patient whose glucose falls while ketones and acidosis persist, add the protocol dextrose and continue appropriately adjusted insulin rather than stopping because glucose is normal. Recheck potassium and the precipitating illness. A rising sodium during HHS treatment may reflect glucose correction rather than an automatic need for hypotonic fluid; interpret measured sodium with osmolality and volume response. If fluids worsen respiratory distress, reassess overload and obtain senior support. Resolution requires the specified biochemical/clinical criteria, not a single improved capillary glucose.

Chronic Microvascular & Macrovascular Complications

Diabetic Retinopathy : Pathophysiological Manifestation: Non-proliferative (microaneurysms, dot-and-blot haemorrhages, cotton wool spots, hard exudates) vs Proliferative (neovascularisation, vitreous haemorrhage, retinal detachment); Screening Standard in Australia: Dilated fundoscopy or digital retinal photography every 2 years (annually if abnormalities identified); Evidence-Based Intervention: Glycaemic and BP control; pan-retinal photocoagulation (PRP); intravitreal anti-VEGF agents (aflibercept, ranibizumab) for macular oedema

Diabetic Neuropathy : Pathophysiological Manifestation: Distal symmetrical sensorimotor polyneuropathy (glove-and-stocking pattern); autonomic neuropathy (gastroparesis, postural hypotension, cardiac denervation, erectile dysfunction); Screening Standard in Australia: Annual 10-g Semmes-Weinstein monofilament test and 128 Hz 128\text{ Hz} 128 Hz tuning fork vibration testing; structured foot inspection for ulcers/calluses; Evidence-Based Intervention: Glycaemic control; podiatry care; custom pressure-relieving footwear; symptomatic neuropathic pain management (duloxetine, pregabalin, amitriptyline)

Macrovascular Disease : Pathophysiological Manifestation: Accelerated coronary artery disease, ischaemic stroke, and peripheral arterial disease driven by endothelial dysfunction and atheroma formation; Screening Standard in Australia: Use the current Australian CVD risk calculator in eligible primary-prevention patients, including people with diabetes aged 35–79; apply earlier First Nations assessment and recommended review intervals. Established CVD requires secondary prevention; Evidence-Based Intervention: Statin therapy (target LDL < 1.8 mmol/L < 1.8\text{ mmol/L} < 1.8 mmol/L , or < 1.4 mmol/L < 1.4\text{ mmol/L} < 1.4 mmol/L in known ASCVD); blood pressure target < 130 / 80 mmHg < 130/80\text{ mmHg} < 130/80 mmHg ; antiplatelet therapy (aspirin 100 mg 100\text{ mg} 100 mg secondary prevention)

Primary references (checked 7 October 2026): 2024 hyperglycaemic-crisis consensus .